Brillia Health Cough Control is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Hadaf Llc. The primary component is Lapine Morphine Immune Globulin; Lapine Bradykinin Immune Globulin; Lapine Histamine Immune Globulin.
| Product ID | 72123-005_abc7b21e-76fd-0b6b-e053-2a95a90aaf51 |
| NDC | 72123-005 |
| Product Type | Human Otc Drug |
| Proprietary Name | Brillia Health Cough Control |
| Generic Name | Homeopathic |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-07-31 |
| Marketing Category | UNAPPROVED HOMEOPATHIC / |
| Labeler Name | Hadaf LLC |
| Substance Name | LAPINE MORPHINE IMMUNE GLOBULIN; LAPINE BRADYKININ IMMUNE GLOBULIN; LAPINE HISTAMINE IMMUNE GLOBULIN |
| Active Ingredient Strength | 12 [hp_C]/12[hp_C]; [hp_C]/12[hp_C]; [hp_C]/12[hp_C] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 72123-005 | Brillia Health Cough Control | homeopathic |
| 72123-007 | Brillia Health Cough Control | Lapine Bradykinin Immune Globulin (12C, 30C, 50C), Lapine Morphine Immune Globulin (12C, 30C, 50C), Lapine Histamine Immune Globulin (12C, 30C, 50C) |
| 72123-004 | Brilla Health Cold-Flu Recovery | homeopathic |